Bursa Announcements
Stock Name / Code :
DPHARMA ( 7148 )
Year :
2026
2025
2024
2023
2022
Archives
Select Date Range :
Categories :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Filter
Reset
Wednesday - 21 May 2025
OTHERS
Duopharma Biotech Maintains Focus on Domestic Market Leadership and International Growth
Tuesday - 20 May 2025
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
OTHERS
AGREEMENT FOR THE PROCUREMENT VIA DIRECT NEGOTIATION FOR THE SUPPLY OF INSULIN MEDICINE AS A PACKAGE ('PERJANJIAN PEROLEHAN SECARA RUNDINGAN TERUS PEMBEKALAN UBAT INSULIN RECOMBINANT HUMAN 100IU/ML PENFILL/REFILL SECARA PAKEJ') PURSUANT TO THE ACCEPTANCE OF TENDER OFFER FOR THE SUPPLY OF RECOMBINANT HUMAN INSULIN FORMULATIONS (HEREINAFTER REFERRED TO AS THE "PRODUCTS") TO THE GOVERNMENT OF MALAYSIA
Monday - 19 May 2025
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Thursday - 15 May 2025
Quarterly rpt on consolidated results for the financial period ended 31 Mar 2025
OTHERS
Duopharma Biotech Records 36.2% Revenue Growth and 67.8% Profit Improvement in Q1 FY2025
OTHERS
Revised Administrative Guide
Wednesday - 14 May 2025
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Tuesday - 13 May 2025
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Monday - 28 Apr 2025
OTHERS
CONTRACTS FOR THE SUPPLY BY DUOPHARMA (M) SENDIRIAN BERHAD, DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. AND DUOPHARMA HAPI SDN. BHD. (ALL WHOLLY-OWNED SUBSIDIARY COMPANIES OF DUOPHARMA BIOTECH BERHAD), THROUGH PHARMANIAGA LOGISTICS SDN. BHD. OF PHARMACEUTICAL AND/OR NON-PHARMACEUTICAL PRODUCTS FOR THE MINISTRY OF HEALTH OF MALAYSIA UNDER THE APPROVED PRODUCTS PURCHASE LIST (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)
Monday - 21 Apr 2025
Annual Audited Accounts - 31 Dec 2024
Annual Report & CG Report - 2024
Friday - 18 Apr 2025
GENERAL MEETINGS: Notice of Meeting
Wednesday - 9 Apr 2025
OTHERS
CONTRACT FOR THE SUPPLY BY DUOPHARMA HAPI SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY COMPANY OF DUOPHARMA BIOTECH BERHAD), THROUGH PHARMANIAGA LOGISTICS SDN. BHD. OF PHARMACEUTICAL AND/OR NON-PHARMACEUTICAL PRODUCTS FOR THE MINISTRY OF HEALTH OF MALAYSIA UNDER THE APPROVED PRODUCTS PURCHASE LIST (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)
Friday - 28 Mar 2025
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
«
1
2
3
4
5
6
7
8
9
10
»